Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases.
10.3760/cma.j.cn112151-20221017-00861
- Author:
Xiao Xi WANG
1
;
Yan LIU
1
;
Ling Chao LIU
1
;
Yu Xiang WANG
1
;
Jing YANG
1
;
A Jin HU
1
;
Bo ZHANG
1
;
Cong Rong LIU
1
Author Information
1. Department of Pathology, Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
- Publication Type:Journal Article
- MeSH:
Female;
Humans;
Adolescent;
Young Adult;
Adult;
Middle Aged;
Fumarate Hydratase/genetics*;
Uterine Neoplasms/pathology*;
Leiomyoma/pathology*;
Germ-Line Mutation;
Diagnosis, Differential;
Leiomyomatosis/pathology*;
Carcinoma, Renal Cell/diagnosis*
- From:
Chinese Journal of Pathology
2023;52(6):574-579
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinicopathologic and molecular characteristics of fumarate hydratase (FH) deficient uterine leiomyoma. Methods: Eighty cases of FH deficient uterine leiomyoma were diagnosed from April 2018 to September 2022 in Department of Pathology, Peking University Third Hospital. Sanger sequencing of FH gene exons (exon 1-10) were performed on tumor tissues and matched non-tumor tissues/peripheral blood for all cases. FH immunohistochemistry were performed in 74 cases; S-(2-succino)-cysteine (2SC) were also detected by immunohistochemistry in five cases. Results: Patients' age ranged from 18 to 54 (36.0±7.5) years, with more than 60% exhibiting clinical symptoms of multiple and large leiomyomas (the median diameter was 70 mm). More than four histologic features, including staghorn vasculature, alveolar-pattern edema, bizarre nuclei, oval nuclei arranged in chains, prominent eosinophilic nucleoli with perinucleolar haloes and eosinophilic intracytoplasmic globules were observed in 98.5% (67/68) patients. The immunohistochemical sensitivity of FH and 2SC were 97.3% and 100%, respectively. Based on the Sanger sequencing results, the cases were divided into germline variant group (31 cases), somatic variant group (29 cases) and no variant group (20 cases). Sixty-nine percent (20/29) of the patients with FH germline variation had clear family history. Conclusions: Clinical features, histological morphology, FH and 2SC immunohistochemistry and Sanger sequencing have their own significance and limitations in differential diagnosis of FH deficient uterine leiomyoma. In clinical practice, the above information should be fully integrated and studied for accurate pathologic diagnosis and selection of patients with FH germline variation.
